Effect of Cilostazol in Platelet Inhibition in Patients With Peripheral Artery Disease

被引：0
|
作者：
Ferreira, Sasha P. Suarez [1 ]
Hall, Ryan
Majumdar, Monica
Goudot, Guillaume [2 ]
Jessula, Samuel [1 ]
Feldman, Zach M.
Bellomo, Tiffany
Lee, Ivy
Owolabi, Lois
Kirshkaln-Leahy, Amanda [1 ]
Nuzzolo, Kathryn
Dua, Anahita [3 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Div Cardiol, Boston, MA USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA
来源：
JOURNAL OF VASCULAR SURGERY | 2023年 / 77卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
PC186
引用
收藏
页码：E326 / E327
页数：2
相关论文
共 50 条
  • [31] Cilostazol and peripheral arterial disease
    Pearce, Lyndsay
    Ghosh, Jonathan
    Counsell, Andrew
    Serracino-Inglott, Ferdinand
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (15) : 2683 - 2690
  • [32] Cilostazol for peripheral arterial disease
    Robless, P.
    Mikhailidis, D. P.
    Stansby, G. P.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (01):
  • [33] Plasma Levels of snoRNAs are Associated with Platelet Activation in Patients with Peripheral Artery Disease
    Nossent, Anne Yael
    Ektefaie, Neda
    Wojta, Johann
    Eichelberger, Beate
    Kopp, Christoph
    Panzer, Simon
    Gremmel, Thomas
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (23)
  • [34] The use of cilostazol in intermittent claudication in patients with peripheral arterial disease
    Wierzchowski, Pawel
    Migdalski, Arkadiusz
    Jawien, Arkadiusz
    ACTA ANGIOLOGICA, 2014, 20 (03): : 101 - 105
  • [35] The vascular and biochemical effects of cilostazol in patients with peripheral arterial disease
    O'Donnell, Mark E.
    Badger, Stephen A.
    Sharif, Mohammed A.
    Young, Ian S.
    Lee, Bernard
    Soong, Chee V.
    JOURNAL OF VASCULAR SURGERY, 2009, 49 (05) : 1226 - 1234
  • [36] Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease - Discussion
    Patterson, RB
    Money, SR
    Porter, JM
    Moore, WS
    JOURNAL OF VASCULAR SURGERY, 1998, 27 (02) : 274 - 275
  • [37] The effect of atorvastatin on platelet function in patients with coronary artery disease
    Tekten, T
    Ceyhan, C
    Ercan, E
    Onbasili, AO
    Turkoglu, C
    ACTA CARDIOLOGICA, 2004, 59 (03) : 311 - 315
  • [38] Cilostazol Improves Long-term Survival After Endovascular Therapy in Hemodialysis Patients With Peripheral Artery Disease
    Kumada, Yoshitaka
    Ishii, Hideki
    Aoyama, Toru
    Tanaka, Miho
    Kamoi, Daisuke
    Kawamura, Yoshihiro
    Takahashi, Hiroshi
    Murohara, Toyoaki
    CIRCULATION, 2009, 120 (18) : S921 - S921
  • [39] Real-World Safety and Effectiveness of Controlled-Release Cilostazol in Patients with Symptomatic Peripheral Artery Disease
    Shin, Woo-young
    Lee, Hye Jun
    Kim, Jung-ha
    CLINICAL DRUG INVESTIGATION, 2023, 43 (9) : 729 - 738
  • [40] Real-World Safety and Effectiveness of Controlled-Release Cilostazol in Patients with Symptomatic Peripheral Artery Disease
    Woo-young Shin
    Hye Jun Lee
    Jung-ha Kim
    Clinical Drug Investigation, 2023, 43 : 729 - 738
12345